Shanghai-listed Chinese drug maker Joincare Pharmaceutical Group Industry has entered into an agreement to raise up to 2.17 billion yuan ($310 million) from Asia-focused Hillhouse Capital Management through a private placement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
